GENE ONLINE|News &
Opinion
Blog

mRNA Technology
Special mRNA
Moving Beyond COVID With mRNA Technology
2023-01-18
Trials & Approvals Moderna
Moderna’s Personalized Cancer Therapy: The New Transformative Approach to Oncology
2022-12-08
Partnerships Keytruda
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
Funding mRNA Technology
Singapore’s RVAC Medicines Raises $140 Million for mRNA Ambitions
2022-04-28
Asia-Pacific Moderna
Moderna Announces Plan to Set Up Subsidiaries in APAC to Provide mRNA Technology Service
2022-02-16
Special Best of 2021
GeneOnline’s Pick: Novel Biotechnologies that Made a Splash in 2021
2022-01-27
COVID-19 Vaccine
Arcturus’ COVID Vaccine Moves to Phase 2 Trial in Singapore
2021-01-05
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top